Kandal M Venture Limited filed a Form 6-K on November 5, 2026, disclosing that it received formal notification from Nasdaq on October 30, 2026, confirming the company had regained compliance with the Nasdaq minimum bid price listing requirement.
Horizon Quantum Holdings Ltd. filed a Form 6-K on November 5, 2026, disclosing that the company entered into a non-binding letter of intent to acquire Entropica Labs Pte. Ltd. for approximately $27 million in Class A ordinary shares.
Core Natural Resources, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting third-quarter net income of $8.998 million and nine-month net income of $156.509 million.
Keel Infrastructure Corp. (NASDAQ:KEEL), formerly known as Bitfarms Ltd., filed its quarterly report on Form 10-Q for the quarter ended September 30, 2026, with the SEC on November 5, 2026.
Cartesian Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.
Madison Air Solutions Corporation (NYSE:MAIR) filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, disclosing share counts, segment data, and details on a pending acquisition.
News Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting first-quarter results that included total revenues of $2,281 million and net income attributable to stockholders of $159 million.
Avalo Therapeutics, Inc. filed a Form 10-Q with the SEC on November 5, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, including a net loss of $74,933 thousand for the nine months ended September 30, 2026.
Real REMAX Group Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing a significantly expanded balance sheet following what the filing describes as the combination of the legacy REMAX and Real businesses.
Evolent Health, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.